Qualigen Therapeutics, Inc.
Qualigen Therapeutics, Inc. (QLGN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · QLGN · as of Jun 9, 2026
Key Statistics
Explore Qualigen Therapeutics, Inc. Data
qlgn stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
qlgn competitorsQLGN
CANF
CMND
CNSP
ENSC
KALAStock Performance
Full HistoryAbout Qualigen Therapeutics, Inc.
Qualigen Therapeutics, Inc. is a biotechnology enterprise focused on advancing groundbreaking treatments for both cancer and infectious diseases. In addition to its developmental pipeline, the company…
what is qualigen therapeutics, inc. · qlgn stock overview · qualigen therapeutics, inc. company profile · who is qualigen therapeutics, inc. ceo · qlgn NASDAQ · qualigen therapeutics, inc. headquarters · qualigen therapeutics, inc. business segments
About Stock Overview & Key Data
Qualigen Therapeutics, Inc. (QLGN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 23, 2015. As of the latest trading session, QLGN stock price is $3.21, with a market capitalization of $5.4M. The stock has returned -17.69% over the past 12 months and -23.57% year-to-date.
In fiscal year 2025, Qualigen Therapeutics, Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Qualigen Therapeutics, Inc. (QLGN) stock price is $3.21. The stock is traded on NASDAQ under the ticker symbol QLGN. The 52-week range is $1.61 – $8.81.